Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TROP2 ADC, Breast Cancer

Ines Vaz-Luis

MD, PhD

🏢Gustave Roussy Cancer Campus🌐France

Medical Oncologist and Clinical Researcher

27
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Ines Vaz-Luis is a breast oncologist and outcomes researcher at Gustave Roussy who has contributed to TROPiCS-02, which demonstrated survival benefit of sacituzumab govitecan in heavily pre-treated HR-positive HER2-negative metastatic breast cancer. Her research spans outcomes and quality of life in breast cancer as well as novel systemic therapies including TROP2-directed ADCs.

Share:

🧪Research Fields 研究领域

TROPiCS-02 HR+ breast cancer
sacituzumab govitecan HR+ BC
TROP2 endocrine-resistant breast cancer
metastatic HR+ BC novel therapy
breast cancer quality of life

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Ines Vaz-Luis 的研究动态

Follow Ines Vaz-Luis's research updates

留下邮箱,当我们发布与 Ines Vaz-Luis(Gustave Roussy Cancer Campus)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment